The newsletter provides a quick and effective way to share the latest developments in oncology drug research, including new approvals, health authority review documents, statistical conferences, advancements in statistical methodologies, and updates from working groups. Each edition is centered around a specific theme, and we invite leading experts to share their insights. The editorial team comprises representatives from diverse fields to ensure a broad perspective. If you are interested in contributing to the newsletter series or would like to volunteer to the editorial team, please contact us.